<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta />
    <article-meta>
      <title-group>
        <article-title>Knowledge Engineering Framework to Quantify Dependencies between Epidemiological and Biomolecular Factors in Breast Cancer</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <string-name>Iuliia Innokenteva</string-name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Richard Hammer</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Dmitriy Shin</string-name>
          <email>shindm@health.missouri.edu</email>
          <xref ref-type="aff" rid="aff0">0</xref>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <aff id="aff0">
          <label>0</label>
          <institution>Department of Pathology and Anatomical Sciences University of Missouri, 1 Hospital Dr. Pathology</institution>
          ,
          <addr-line>Med Sci Bldg, Columbia, MO, 65203</addr-line>
          ,
          <country country="US">USA</country>
        </aff>
        <aff id="aff1">
          <label>1</label>
          <institution>MU Informatics Institute</institution>
        </aff>
      </contrib-group>
      <abstract>
        <p>The relationship between social determinants of health (SDoH) and chronic disease risks is crucial for its prevention. Such associations are relatively easier to uncover for simple diseases such as obesity or heart diseases. But for complex diagnoses like cancer, a large number of factors contribute to the onset of the disease. For instance, there is increasing evidence that biomolecular factors of cancer can be influenced by behavioral and environmental patterns. For example, several subtypes of breast cancer that respond to different hormonal therapies can arise due to different lifestyle, social, physiological risk-factors. Cancer Registries and EHRs as the sources of health data are used widely in epidemiological research. Being collected by health professional, the EHR data reduce research cost and embraces the whole population. However, the primary purpose of those records is not being used in a research. Therefore, data adjusting issue can arise. Often the structure of records is not satisfying to build an epidemiological model.  To fit data from EHR and Cancer Registry to epidemiological model we propose the method of knowledge engineering to construct Bayesian Networks (BN) structure using control vocabularies. Specifically, we selected fields from records and used National Institute of Cancer Thesaurus to determine nodes for BN structure. We demonstrate utility of this approach on a cohort of University of Missouri Hospital (UMH) patients who was diagnosed with breast cancer. </p>
      </abstract>
      <kwd-group>
        <kwd>Breast Cancer</kwd>
        <kwd>Epidemiology</kwd>
        <kwd>Controlled Vocabulary</kwd>
        <kwd>Ontology</kwd>
        <kwd>Bayesian Network</kwd>
        <kwd>Knowledge Engineering</kwd>
        <kwd>Biomolecular factors</kwd>
        <kwd>Hormone Receptors</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec-1">
      <title>-</title>
      <p>Recently, EHRs has been used largely as a source of health data for epidemiological
research. Readily available data collected in accordance with health facilities’ standards
help reducing research costs and saving time. Systematic review made by Casey et al.
shows that extract, transform, load (ETL) tool is mainly used to make health data
suitable for researchers (Casey, et al., 2016). Different common data models (CDM) such
as Observational Medical Outcomes Partnership (OMOP), FDA Sentinel Initiative, and
the Patient Centered Outcome Research Network (PCORNet) are based on ETL
approach (Califf, 2014; Carnahan, et al., 2014; Kahn, et al., 2012). CDMs listed above
aim to integrate and adjust health data from diverse sources such as health care
providers, pharmacies, laboratories, etc. The adjustment part of CDM technique is to bring
the data to the same consistent format using controlled vocabularies (e.g., same variable
names, attributes, etc.) (Resnic, et al., 2015). However, it is not well suited for the
selection of pertinent variables to design specific research studies, especially in the
domain of complex diseases, such as cancer.</p>
      <p>According to the World Health Organization (WHO), one-third of all cancer cases
can be prevented by having dietary changes, stopping from smoking, getting hepatitis
vaccinations, and exercising regularly. Breast cancer is the most commonly diagnosed
cancer worldwide and particularly in the USA (WHO, 2016). Still, it is one of the
cancer types which can be partially prevented by lifestyle modification (CDC,
2018). There are specific subtypes of breast cancer, which are characterized by different
hormonal patterns. The most commonly used at breast cancer diagnostic and
treatment hormone receptors are estrogen receptor (ER), progesterone receptor (PR),
and human epidermal growth factor receptor 2 (HER2). In accordance with their
presence or absence in a body, breast cancer is divided into subtypes. For instance, luminal
cancer tends to be ER negative, basal-like breast cancer is usually triple negative and it
is the most challenging type of the disease.</p>
      <p>
        Association between lifestyle factors and those two breast cancer subtypes is shown
in Butler et al study. According to it, smoking is positively associated with luminal
cancer and almost does not effect basal-like cancer (Butler et al., 2016). Similar study
considered obesity as a risk-factor and a significant association between triple negative
breast cancer and obesity was found (Turkoz, et al., 2013). Smoking and ER-positive
cancer analysis showed that current smokers are more susceptible for ER-positive
breast cancer (Odds Ratio [OR]=1.6) than ever smokers (OR=1.4). But there was no
difference in terms of triple negative cancer risk in both groups
        <xref ref-type="bibr" rid="ref4">(Kawai, Malone, Tang,
&amp; Li, 2014)</xref>
        . Statistical evidence of associations between obesity and ER-positive
cancer was proven in Nechuta et al. study. The same research showed strong correlation
between alcohol consumption and ER-positive breast cancer (Nechuta, et al.,
2016). However, some studies presented that higher body mass index increases breast
cancer risk independently on menopausal status and estrogen receptor (ER) expression
(Schirer, et al., 2013; Wada et al., 2014). Another interesting finding is that urban
women have higher incidence rates (IRR) of ER-positive breast cancer (IRR=3.36) than
rural women (Dey, et al., 2009). After reviewing literature described above, we
have determined potential risk factors for all subtypes of breast cancer. Smoking,
alcohol consumption, obesity had been chosen as initial variables for our research.
Additionally, we considered the most common comorbidities such as hypertension and
diabetes as risk-factors.
      </p>
      <p>Combination of molecular biology approaches and epidemiology studies can help to
determine the causes of certain subtype of breast cancer. Bayesian Networks can be
instrumental to model such processes. BN is a graphical model that represents
relationships between factors and their probabilities. The model is usually used for prediction
of disease risk depending on certain factors (Rosa, et al., 2015). Each variable is
represented as a node of BN and it has several mutually exclusive instances. Changing
instances for independent variables and setting a dependent variable as a target we can
predict an outcome.</p>
      <p>Still, it is not a trivial process to select appropriate entities from a EHR to determine
nodes for a BN model. Specifically, there has to be a protocol to determine appropriate
level of granularity for those entities. For instance, several fields in EHR system might
have to be aggregated to represent a node in BN model.   </p>
      <p>To address this problem, we aim to create a knowledge
engineering framework utilizing controlled vocabularies such as ontologies and thesauri. Determined through
such a process BN nodes are then connected in a structure to compute conditional
probabilities. Then the BN model can be used to quantify and predict factors that
influences hormonal patterns of breast cancer, which can lead to better patient care.   
2</p>
    </sec>
    <sec id="sec-2">
      <title>Methods </title>
      <p>The pipeline of knowledge engineering process is shown on Figure 1.</p>
      <p>Data are selected from EHR and Cancer registry based on epidemiological
knowledge about breast cancer. There is number of possible factors contributing to an
onset of breast cancer including demographic, socio-economic, physiological, and
mental factors. For the given research we used risk factors that were available in UMH
EHRs and Cancer Registry records. Ontology is used to determine which EHR fields
can be aggregated. We used the National Cancer Institute (NCI) Thesaurus to select
potential cancer risk factors that later could be retrieved from EHR. For example,
according to NIC Thesaurus, variables ‘Type 1 Diabetes Mellitus’ and ‘Type 2 Diabetes
Mellitus’ are the child concepts of ‘Diabetes Mellitus’ concept. Thus, depending on
epidemiological context those variables can be aggregated in one BN node “Diabetes
Mellitus’ with possible values ‘Type 1’, ‘Type 2’, ‘Undefined Diabetes’, ‘No History of
Diabetes’.</p>
      <p>To generate the BN structure, we used epidemiological knowledge and literature
review presented in the introduction. In addition to history of obesity, tobacco and
alcohol consumption we included comorbidities such as diabetes and hypertension. We
added a race variable as well to make the causality pattern more representative.
Generated BN structure and its nodes are shown in Figure 2.</p>
      <p>For the generated structure, we learned parameters from the dataset of 980 patients
of UMH with diagnosed breast cancer. Then setting ‘Hormonal_Pattern’ node as a
target and setting different values for other nodes we could simulate cases and predict
hormonal pattern of breast cancer depending on behavioral, health, and social factors
(Figure 3).</p>
      <p>Using UMH Cancer Registry data we determined a cohort of 1070 patients who were
diagnosed with breast cancer after 2013. Information about race, history of tobacco and
alcohol use, estrogen receptor (ER), progesterone receptor (PR), human epidermal
growth factor receptor 2 (HER2) was found from cancer registry data. Information
about history of obesity, diabetes, and hypertension was added from UMH EHRs.
Hormonal patterns were defined as eight combinations of ER, PR, HER2 different values,
positive or negative (Table 1). During the data cleaning process 90 cases were removed
because of missing values.</p>
      <p>Table 2 contains randomly selected five cases with different values of nodes. The
results of simulation for five given cases are presented on the Table 2 as probabilities
of different combinations of ER, PR, HER2 values.</p>
      <p>The results of simulating different cases with certain values show that some variables
influence more than others on the ‘hormonal pattern’ outcome. Changing values one by
one, we can see which of the nodes has the major effect on hormone receptors pattern.
This approach can be used to predict a risk of certain subtype of breast cancer
depending on a variety of factors. In a best-case scenario, we could predict triple negative
breast cancer risk which is the most challenging subtype of the disease in terms of
response for a therapy.</p>
      <p>Using the knowledge engineering pipeline presented in the study, one can add
variables from different sources and aggregate them using ontology. For instance, EHRs
contain patients’ addresses and it can be useful source of information in
epidemiological sense. The thesaurus has a class called ‘Group’ which is then divided into
‘rural/underserved population’ and ‘urban population’. To extract this useful information,
the nominal ‘address’ variable from the EHR needs to be modified to rural/urban
categorical variable. Then it can be included in epidemiological model to predict breast
cancer subtype depending on patients’ residency which represents an access to health
care.</p>
      <p>For the epidemiological model of breast cancer hormonal patterns, we did not include
all possible predictors of the disease such as age, marital status, age at menarche, age
at menopause, number of pregnancies. The purpose of the model is to show the
possibility of utilizing the pipeline for certain population health research.</p>
      <p>Future research can be done to validate the results of this study. Using data analysis
statistical tools such as STATA one can analyze associations between nodes and find
evidence of statistical significance.
4</p>
    </sec>
    <sec id="sec-3">
      <title>Conclusion</title>
      <p>To address the problem of determining the granularity of the data entities from
different sources, we created a knowledge engineering pipeline. By utilizing the pipeline,
we could modify types of information from EHR and Cancer Registry records using a
controlled vocabulary such as NIC Thesaurus. We converted those variables into useful
for epidemiological models form. The utilization of this pipeline is not limited by
cancer epidemiology purposes only. It can be used for other population health research
aimed to study health care access, behavioral patterns, treatment or public health
program effectiveness, and many other aspects.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <mixed-citation>
          (
          <year>2016</year>
          ).
          <article-title>Active smoking and risk of Luminal and Basal-like breast cancer subtypes in the Carolina Breast Cancer Study</article-title>
          .
          <source>Cancer Causes &amp; Control : CCC.</source>
        </mixed-citation>
      </ref>
      <ref id="ref2">
        <mixed-citation>
          https://doi.org/10.1007/s10552-016-0754-1 Califf,
          <string-name>
            <surname>R. M.</surname>
          </string-name>
          (
          <year>2014</year>
          ).
          <source>The Patient-Centered Outcomes Research Network. North Carolina Medical Journal</source>
          ,
          <volume>75</volume>
          (
          <issue>3</issue>
          ),
          <fpage>204</fpage>
          -
          <lpage>210</lpage>
          . doi:
          <volume>10</volume>
          .18043/ncm.75.3.204 Carnahan,
          <string-name>
            <given-names>R. M.</given-names>
            ,
            <surname>Bell</surname>
          </string-name>
          ,
          <string-name>
            <given-names>C. J.</given-names>
            , &amp;
            <surname>Platt</surname>
          </string-name>
          ,
          <string-name>
            <surname>R.</surname>
          </string-name>
          (
          <year>2014</year>
          ).
          <article-title>Active Surveillance: The United States Food and Drug Administrations Sentinel Initiative</article-title>
          .
          <source>Manns Pharmacovigilance</source>
          ,
          <fpage>429</fpage>
          -
          <lpage>437</lpage>
          . doi:
          <volume>10</volume>
          .1002/9781118820186.ch2 Casey,
          <string-name>
            <given-names>J. A.</given-names>
            ,
            <surname>Schwartz</surname>
          </string-name>
          ,
          <string-name>
            <given-names>B. S.</given-names>
            ,
            <surname>Stewart</surname>
          </string-name>
          ,
          <string-name>
            <given-names>W. F.</given-names>
            , &amp;
            <surname>Adler</surname>
          </string-name>
          ,
          <string-name>
            <surname>N. E.</surname>
          </string-name>
          (
          <year>2016</year>
          ).
          <article-title>Using Electronic Health Records for Population Health Research: A Review of Methods and Applications</article-title>
          .
          <source>Annual Review of Public Health</source>
          ,
          <volume>36</volume>
          ,
          <fpage>61</fpage>
          -
          <lpage>81</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref3">
        <mixed-citation>
          <article-title>Centers for Disease Control and Prevention</article-title>
          .
          <source>Breast Cancer</source>
          . (
          <year>2018</year>
          , May 22). Retrieved from https://www.cdc.gov/cancer/breast/index.htm Dey,
          <string-name>
            <given-names>S.</given-names>
            ,
            <surname>Soliman</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A. S.</given-names>
            ,
            <surname>Hablas</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            ,
            <surname>Seifeldin</surname>
          </string-name>
          ,
          <string-name>
            <given-names>I. A.</given-names>
            ,
            <surname>Ismail</surname>
          </string-name>
          ,
          <string-name>
            <given-names>K.</given-names>
            ,
            <surname>Ramadan</surname>
          </string-name>
          ,
          <string-name>
            <given-names>M.</given-names>
            , . . .
            <surname>Merajver</surname>
          </string-name>
          ,
          <string-name>
            <surname>D.</surname>
          </string-name>
          (
          <year>2009</year>
          , June 23).
          <article-title>Urban-rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt</article-title>
          . Retrieved from https://link.springer.com/article/10.1007/s10549-009-0427-9, https://doi.org/10.1007/s10549-009-0427-9 Kahn,
          <string-name>
            <given-names>M. G.</given-names>
            ,
            <surname>Batson</surname>
          </string-name>
          ,
          <string-name>
            <given-names>D.</given-names>
            , &amp;
            <surname>Schilling</surname>
          </string-name>
          ,
          <string-name>
            <surname>L. M.</surname>
          </string-name>
          (
          <year>2012</year>
          ).
          <article-title>Data Model Considerations for Clinical Effectiveness Researchers</article-title>
          .
          <source>Medical Care</source>
          ,
          <volume>50</volume>
          .
        </mixed-citation>
      </ref>
      <ref id="ref4">
        <mixed-citation>
          <source>doi:10</source>
          .1097/mlr.0b013e318259bff4 Kawai,
          <string-name>
            <given-names>M.</given-names>
            ,
            <surname>Malone</surname>
          </string-name>
          ,
          <string-name>
            <given-names>K. E.</given-names>
            ,
            <surname>Tang</surname>
          </string-name>
          , M.-
          <string-name>
            <given-names>T. C.</given-names>
            , &amp;
            <surname>Li</surname>
          </string-name>
          ,
          <string-name>
            <surname>C. I.</surname>
          </string-name>
          (
          <year>2014</year>
          ).
          <article-title>Active smoking and the risk of estrogen receptor-positive and triple-negative breast cancer among women ages 20 to 44 years</article-title>
          . Cancer,
          <volume>120</volume>
          (
          <issue>7</issue>
          ),
          <fpage>1026</fpage>
          -
          <lpage>1034</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref5">
        <mixed-citation>
          https://doi.org/10.1002/cncr.28402 Nechuta,
          <string-name>
            <given-names>S.</given-names>
            ,
            <surname>Chen</surname>
          </string-name>
          , W. Y.,
          <string-name>
            <surname>Cai</surname>
            ,
            <given-names>H.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Poole</surname>
            ,
            <given-names>E. M.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Kwan</surname>
            ,
            <given-names>M. L.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Flatt</surname>
            ,
            <given-names>S. W.</given-names>
          </string-name>
          , … Ou Shu,
          <string-name>
            <surname>X.</surname>
          </string-name>
          (
          <year>2016</year>
          ).
          <article-title>A pooled analysis of post-diagnosis lifestyle factors in association with late estrogen-receptor-positive breast cancer prognosis</article-title>
          .
          <source>International Journal of Cancer</source>
          . https://doi.org/10.1002/ijc.29940 Resnic,
          <string-name>
            <given-names>F.</given-names>
            ,
            <surname>Robbins</surname>
          </string-name>
          ,
          <string-name>
            <given-names>S.</given-names>
            ,
            <surname>Denton</surname>
          </string-name>
          ,
          <string-name>
            <given-names>J.</given-names>
            ,
            <surname>Nookala</surname>
          </string-name>
          ,
          <string-name>
            <given-names>L.</given-names>
            ,
            <surname>Meeker</surname>
          </string-name>
          ,
          <string-name>
            <given-names>D.</given-names>
            ,
            <surname>Ohno-Machado</surname>
          </string-name>
          ,
          <string-name>
            <surname>L.</surname>
          </string-name>
          , . . .
        </mixed-citation>
      </ref>
      <ref id="ref6">
        <mixed-citation>
          <string-name>
            <surname>Fitzhenry</surname>
            ,
            <given-names>F.</given-names>
          </string-name>
          (
          <year>2015</year>
          ).
          <article-title>Creating a Common Data Model for Comparative Effectiveness with the Observational Medical Outcomes Partnership</article-title>
          . Applied Clinical Informatics,
          <volume>06</volume>
          (
          <issue>03</issue>
          ),
          <fpage>536</fpage>
          -
          <lpage>547</lpage>
          . doi:
          <volume>10</volume>
          .4338/aci-2014-12-cr-0121
          <string-name>
            <surname>Rosa</surname>
            ,
            <given-names>C. M. I.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Simões</surname>
            ,
            <given-names>P. W.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Doneda</surname>
            ,
            <given-names>G.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Silva</surname>
            ,
            <given-names>D.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Moretti</surname>
            ,
            <given-names>G. P.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Simon</surname>
            ,
            <given-names>C. S.</given-names>
          </string-name>
          , …
          <string-name>
            <surname>Rosa</surname>
            ,
            <given-names>M. I.</given-names>
          </string-name>
          (
          <year>2015</year>
          ).
          <article-title>Meta analysis of the use of Bayesian networks in breast cancer diagnosis</article-title>
          .
          <source>Cad. Saúde Pública</source>
          ,
          <volume>31</volume>
          (
          <issue>311</issue>
          ),
          <fpage>26</fpage>
          -
          <lpage>3826</lpage>
          . https://doi.org/10.1590/
          <fpage>0102</fpage>
          - 311X00205213
          <string-name>
            <surname>Schairer</surname>
            ,
            <given-names>C.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Li</surname>
            ,
            <given-names>Y.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Frawley</surname>
            ,
            <given-names>P.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Graubard</surname>
            ,
            <given-names>B. I.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Wellman</surname>
            ,
            <given-names>R. D.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Buist</surname>
            ,
            <given-names>D. S. M.</given-names>
          </string-name>
          , …
          <string-name>
            <surname>Miglioretti</surname>
            ,
            <given-names>D. L.</given-names>
          </string-name>
          (
          <year>2013</year>
          ).
          <article-title>Risk factors for inflammatory breast cancer and other invasive breast cancers</article-title>
          .
          <source>Journal of the National Cancer Institute.</source>
        </mixed-citation>
      </ref>
      <ref id="ref7">
        <mixed-citation>
          https://doi.org/10.1093/jnci/djt206 Turkoz,
          <string-name>
            <given-names>F. P.</given-names>
            ,
            <surname>Solak</surname>
          </string-name>
          ,
          <string-name>
            <given-names>M.</given-names>
            ,
            <surname>Petekkaya</surname>
          </string-name>
          ,
          <string-name>
            <given-names>I.</given-names>
            ,
            <surname>Keskin</surname>
          </string-name>
          ,
          <string-name>
            <given-names>O.</given-names>
            ,
            <surname>Kertmen</surname>
          </string-name>
          ,
          <string-name>
            <given-names>N.</given-names>
            ,
            <surname>Sarici</surname>
          </string-name>
          ,
          <string-name>
            <given-names>F.</given-names>
            , …
            <surname>Altundag</surname>
          </string-name>
          ,
          <string-name>
            <surname>K.</surname>
          </string-name>
          (
          <year>2013</year>
          ).
          <article-title>Association between common risk factors and molecular subtypes in breast cancer patients</article-title>
          .
          <source>The Breast</source>
          ,
          <volume>22</volume>
          (
          <issue>3</issue>
          ),
          <fpage>344</fpage>
          -
          <lpage>350</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref8">
        <mixed-citation>
          https://doi.org/10.1016/J.BREAST.
          <year>2012</year>
          .
          <volume>08</volume>
          .005 Wada,
          <string-name>
            <given-names>K.</given-names>
            ,
            <surname>Nagata</surname>
          </string-name>
          ,
          <string-name>
            <given-names>C.</given-names>
            ,
            <surname>Tamakoshi</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            ,
            <surname>Matsuo</surname>
          </string-name>
          ,
          <string-name>
            <given-names>K.</given-names>
            ,
            <surname>Oze</surname>
          </string-name>
          ,
          <string-name>
            <given-names>I.</given-names>
            ,
            <surname>Wakai</surname>
          </string-name>
          ,
          <string-name>
            <surname>K.</surname>
          </string-name>
          , …
          <article-title>Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan</article-title>
          . (
          <year>2014</year>
          ).
          <article-title>Body mass index and breast cancer risk in Japan: a pooled analysis of eight population-based cohort studies</article-title>
          .
          <source>Annals of Oncology : Official Journal of the European Society for Medical Oncology / ESMO.</source>
        </mixed-citation>
      </ref>
      <ref id="ref9">
        <mixed-citation>
          https://doi.org/10.1093/annonc/mdt542 World Health Organization.
          <article-title>Breast cancer: Prevention and control</article-title>
          .
          <source>(2016, January</source>
          <volume>21</volume>
          ).
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>